Structural and functional characterisation of cytidine monophosphate-N-acetylneuraminic acid hydroxylase - BfH, IBB, ENWW
Structural and functional characterisation of cytidine monophosphate-N-acetylneuraminic acid hydroxylase - BfH, IBB, ENWW
批准号:
1810160
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMAH) catalyses the conversion of sialic acid N-acetylneuraminic acid (Neu5Ac) to N-glycolylneuraminic acid (Neu5Gc) in animal cells. Sialic acids constitute the outermost components of cell surface glycoproteins and glycolipids and are involved in cell-cell recognition and cell-pathogen interactions. CMAH is a member of metallo-lactamase (MBL) fold superfamily that was first discovered in bacterial enzymes hydrolysing -lactam antibiotics and which is important in drug resistance. Members of MBL fold superfamily are found in animals, plants and fungi and have diverse functions including hydrolysis and redox reactions. CMAH is a unique redox enzyme containing a Rieske [2Fe2S] centre and a mononuclear iron atom and is predicted to require molecular oxygen for the reaction to proceed. Human CMAH is catalytically inactive due to an N-terminal deletion event which occurred around 3 million years ago after the last common ancestor of humans and great apes but before emergence of modern humans. Loss of CMAH function likely had implications in various processes involving sialic acids, such as cell-cell and cell-pathogen interactions leading to changes in susceptibility to some sialic acid recognising pathogens (including malaria parasites and influenza viruses) as well as sugar metabolism. Despite being catalytically inactive, human CMAH is still expressed suggesting it may have an alternative function. Little is known about the mechanism of action of the active animal CMAH and the potential alternative function of the catalytically inactive human enzyme and to date there is no three-dimensional structure of any CMAH homologue available. During this project I am going to investigate structure and function of both the truncated human CMAH and its catalytically active mouse homologue using X-ray crystallography, kinetic and biophysical characterisation as well as cell-based assays. Understanding CMAH function and the effect of the inactivating deletion in humans will shed new light on susceptibility to pathogens, diabetes and human evolution while active CMAH is also interesting from and industrial biotechnology perspective because it catalyses difficult chemical process - oxidation (i.e. hydroxylation) of an N-acetyl group.BBSRC priority areasCombating antimicrobial resistance, Nutrition and health, New strategic approaches to industrial biotechnology
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
-
批准号:82371373
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:沃雁
-
依托单位:
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
-
批准号:82371145
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:陶永
-
依托单位:
SMC5-NSMCE2功能异常激活APSCs中p53/p16衰老通路导致脂肪萎缩和胰岛素抵抗的机制研究
-
批准号:82371873
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:乔洁
-
依托单位:
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
-
批准号:82371997
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张春富
-
依托单位:
HK2乳酰化修饰介导巨噬细胞功能障碍在脓毒症中的作用及机制
-
批准号:82372160
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈峰
-
依托单位:
OBSL1功能缺失导致多指(趾)畸形的分子机制及其临床诊断价值
-
批准号:82372328
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:项盈
-
依托单位:
LTB4/BLT1轴调控NLRP3炎症小体对糖尿病认知功能障碍的作用研究
-
批准号:82371213
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:王修哲
-
依托单位:
Identification and quantification of primary phytoplankton functional types in the global oceans from hyperspectral ocean color remote sensing
-
批准号:--
-
项目类别:--
-
资助金额:160万元
-
批准年份:2022
-
负责人:李忠平
-
依托单位:
浸润特性调制的统计热力学研究
-
批准号:21173271
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:周世琦
-
依托单位: